April 25, 2017 / 6:46 AM / 3 months ago

BRIEF-Xvivo Perfusion Q1 EBITDA decreases to SEK 5.0 mln

1 Min Read

April 25 (Reuters) - XVIVO PERFUSION AB

* Q1 OPERATING INCOME BEFORE DEPRECIATION AND AMORTIZATION (EBITDA), EXCLUDING ITEMS AFFECTING COMPARABILITY, AMOUNTED TO SEK 5.0 (7.3) MILLION

* BOARD OF DIRECTORS HAS RESOLVED UPON A NEW ISSUE OF UP TO 181 MSEK DIRECTED TO INSTITUTIONAL INVESTORS

* NET SALES OF NON-DURABLE GOODS IN QUARTER 1 AMOUNTED TO SEK 33.6 (29.1) MILLION, CORRESPONDING TO AN INCREASE OF 16 PERCENT IN SEK

* Q1 NET SALES AMOUNTED TO SEK 37.5 (33.5) MILLION, CORRESPONDING TO AN INCREASE OF 12 PERCENT Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below